NORAD and triple-negative breast carcinoma: We observed that MDA-MB-231, -436, and -468 cell lines, corresponding to triple-negative breast cancer (TNBC), express higher levels of NORAD. On the other hand, the luminal A-like subtype MCF-7 cell line expresses NORAD at comparable levels with control MCF-10A cell line (Figure 1A).